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Genome-wide association studies (GWAS) have identified many
genetic factors underlying complex human traits. However, these fac-
tors have explained only a small fraction of these traits’ genetic heri-
tability. It is argued that many more genetic factors remain undiscov-
ered. These genetic factors likely are weakly associated at the popu-
lation level and sparsely distributed across the genome. In this paper,
we adapt the recent innovations on Tukey’s Higher Criticism (Tukey
[The Higher Criticism (1976) Princeton Univ.]; Donoho and Jin [Ann.
Statist. 32 (2004) 962–994]) to SNP-set analysis of GWAS, and de-
velop a new theoretical framework in large-scale inference to assess
the joint significance of such rare and weak effects for a quantitative
trait. In the core of our theory is the so-called detection boundary, a
curve in the two-dimensional phase space that quantifies the rarity
and strength of genetic effects. Above the detection boundary, the
overall effects of genetic factors are strong enough for reliable detec-
tion. Below the detection boundary, the genetic factors are simply too
rare and too weak for reliable detection. We show that the HC-type
methods are optimal in that they reliably yield detection once the pa-
rameters of the genetic effects fall above the detection boundary and
that many commonly used SNP-set methods are suboptimal. The su-
perior performance of the HC-type approach is demonstrated through
simulations and the analysis of a GWAS data set of Crohn’s disease.
1. Introduction. Genome-wide association studies (GWAS) aim to de-
tect associated genetic factors by scanning up to several million genetic
variants over the whole genome. Although many genetic factors have been
successfully identified for human diseases, genes discovered to date account
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for only a small proportion of overall genetic contribution to many complex
traits [Kraft and Hunter (2009), McCarthy et al. (2008)]. The remaining
genetic factors to be detected likely have weak associations at the popu-
lation level and are relatively rare among the huge number of candidates
in the whole genome [Goldstein (2009), Wade (2009)]. Besides the efforts
to increase sample size and improve disease classification, it is desirable to
develop statistical methods that more effectively detect these rare and weak
genetic signals not yet discovered.
Two types of statistical association methods are commonly used to an-
alyze GWAS data: (1) single-SNP methods that analyze the associations
between a trait and individual SNPs, and (2) SNP-set methods that study
the associations between a trait and sets of SNPs. SNP-set methods were
expected to be more promising than single-SNP methods from a biological
perspective. Since multiple SNPs within the same gene, pathway or other
physical and functional genomic segment could jointly affect disease risk,
joint analysis of a set of such SNPs may better reveal the underlying mech-
anisms of complex traits than individual SNPs do. In the past years, many
SNP-set methods have been proposed [Ballard, Cho and Zhao (2010), Hoh
and Ott (2003), Hoh, Wille and Ott (2001), Li et al. (2009), Luo et al.
(2010), Mukhopadhyay et al. (2010), Peng et al. (2009), Wang and Abbott
(2008), Wang, Li and Bucan (2007), Yang, Hsieh and Fann (2008)]. Despite
the encouraging progress in the literature, there lacks a statistical founda-
tion for when and why the SNP-set methods would outperform single-SNP
methods. In fact, some SNP-set methods are not automatically better, as
we will show in this paper. At the same time, it is critical to know the limit
of any statistical association methods, as well as the “best” of the methods,
especially when genetic effects are rare and weak.
In this paper, we approach these problems from a statistical perspective.
For a set of L SNPs of n individuals, we consider an additive genetic model
Y= β0 + β1X1 + β2X2 + · · ·+ βLXL + ε,(1)
that is frequently used in GWAS [Kraft and Hunter (2009)]. The linear
model is likely an oversimplification but we develop our ideas for this one
first. See further comments in Section 7. Here Y = (Y1, . . . , Yn)
′ is the trait
vector, and Xj = (X1j , . . . ,Xnj)
′ is the genotype vector of the jth SNP,
1 ≤ j ≤ L. The error term ε = (ε1, . . . , εn)′ ∼ N(0, σ2I) is independent of
the genotypes and can be used to represent other genetic and environmental
variations [Falconer, Mackay and Frankham (1996)]. The variance parameter
σ2 is usually unknown and needs to be estimated. The coefficient vector β =
(β1, β2, . . . , βL)
′ is unknown to us, but is presumably rare in the sense that
only a few of the coordinates of β are nonzero. We call the jth coordinate of
β a “signal” if βj 6= 0 and otherwise a “noise.” The term “rare signal” should
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not be confused with “rare genetic variation.” Signal rarity is the sparsity
among features, but rare genetic variation is the sparsity among samples. In
the literature, while signal rarity is well defined, signal weakness is a much
more vague notion. As we will show below, signal weakness may result from
weak genetic effect, small sample size and/or small genetic variation. Signal
weakness is one of the main challenges in analyzing big data, such as GWAS
data: The signals are generally very subtle and hard to find, and it is easy
to be fooled.
Statistical literature on linear regression modeling has focused largely on
the goal of separating the signals from the noise [Ayers and Cordell (2010),
Guan and Stephens (2011), Hoggart et al. (2008), Wu et al. (2009), Xie, Cai
and Li (2011)]. While this goal may provide a perfect solution, it is hard to
reach due to a high demand for strong signals and is often not necessary in
GWAS practice either. Thus, in this paper, we are primarily interested in
the problem of signal detection, where the goal is to discover the associated
SNP-sets rather than to identify the individually associated SNPs.
To understand why signal detection is important, from a statistics point
of view it can be shown that given a rarity level of the signals there is a
threshold effect on the signal strength. That is, signals falling under such a
threshold cannot be separated from noise: for any procedure the sum of the
number of signals that are misclassified as noises and the number of noises
that are misclassified as signals cannot get substantially smaller than the
number of signals. Nonetheless, in many cases while signal rarity and signal
strength prohibit us to separate the signals from the noise, the numerous rare
and weak effects can be combined and utilized in a meaningful way to solve
many challenging problems including, but not limited to, signal detection,
classification and clustering. This challenge has been successfully met, for
example, in Donoho and Jin (2004, 2008), Jin and Wang (2013). From the
genetics point of view, the signal detection problem is of major interest in
the GWAS because the primary target of GWAS is to screen and allocate the
informative genome regions, such as genes, which are more natural genomic
functional units than individual SNPs. Furthermore, to validate associations,
such positive regions will be further studied and individual SNP effects can
still be discovered by refined and reliable experimental methods.
The signal detection problem in the model (1) can be reformulated as a
joint hypothesis testing problem where H0 is
H0 : βj = 0, 1≤ j ≤ L,
that is, no association exists between the trait and the SNP sets, against an
alternative hypothesis H1 that the trait is associated with a small fraction
of SNPs in the sets
H1 : βj 6= 0 only for a small fraction of j, 1≤ j ≤ L.
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See Donoho and Jin (2004) for the subtlety of this problem, where the focus
was on a Stein’s normal means model, which is much simpler than the model
considered here.
Our study contains two key components: the detection boundary for sig-
nal detection and the statistic of Higher Criticism. We now discuss two
components separately.
The detection boundary can be viewed as a way to address the fundamen-
tal capability and limit of SNP-set methods. In the two-dimensional phase
space calibrating the signal rarity and signal strength, the detection bound-
ary is a curve that separates the region of impossibility from the region of
possibility. In the region of impossibility, the signals are so rare and weak
that it is impossible to separate H1 from H0. That is, even for the most
powerful method available, the signals are so rare and weak that it would
have the sum of types I and II error rates to be almost 1. In the region of pos-
sibility, it is possible to separate H1 from H0, and there exists a procedure
whose sum of types I and II error rates is approximately 0.
The study of the detection boundary has two merits. First, the detection
boundary is provided as a function of the rarity and strength of genetic
effects, the SNP-set size, the sample size, the error variance and the al-
lele frequency, and thus simultaneously reveals the roles of these factors in
gene-hunting. The result is applicable to genetic association studies of both
common and rare genetic variants, the latter are the main target of find-
ing the missing genetic factors using deep sequencing technologies [Ansorge
(2009), Mardis (2008), Metzker (2010)]. Second, the detection boundary can
serve as a benchmark for evaluating different SNP-set methods. In particu-
lar, note that any procedure will partition the aforementioned phase spaces
into two regions: a region of possibility and a region of impossibility. We
say a method achieves the optimal phase diagram if it partitions the two-
dimensional phase space in exactly the same way as the optimal procedure
does. As a result, for any procedure we can assess its optimality by investi-
gating whether it achieves the optimal phase diagram.
Higher Criticism (HC) is a notion that goes back to Tukey (1976), and it
was shown in Arias-Castro, Cande`s and Plan (2011), Donoho and Jin (2004),
Hall and Jin (2008, 2010), Ingster, Tsybakov and Verzelen (2010) that HC
is useful in detecting very rare and weak effects. However, these works deal
with models different from the genetic model (1), and it is unclear whether
the HC continues to behave well for the setting considered here. The genetic
model is new in several aspects. First, the covariates are genotype data,
rather than standardized or Gaussian variables. Second, the conditions for
correlations among covariates, that is, the linkage disequilibrium structure,
are better placed on the population correlations, rather than on the empirical
correlations. Third, the error variance is realistically considered as unknown
and needs to be estimated, rather than being assumed as known.
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In this paper we adapt the HC to detect rare and weak genetic effects in
a SNP-set analysis context. With substantial efforts, we work out the ex-
act detection boundary associated with the genetic model (1). We propose
a realistic HC procedure for analyzing real GWAS data and show that it
achieves the optimal phase diagram in a rather broad context. We provide
theoretical comparisons between HC and the several most commonly used
SNP-set methods. Somewhat surprisingly, these well-known SNP-set meth-
ods do not achieve the optimal phase diagram for rare and weak signals. We
further demonstrate the superiority of the HC-type methods with simulated
data and real data.
The paper is organized as follows. In Section 2 we set up the genetic
model and provide the detection boundary for rare and weak genetic effects.
In Section 3 an HC procedure is proposed to reach the optimal detection
boundary for rare and weak genetic signals. In Section 4 we discuss the
connections of HC to False Discovery Rate (FDR) controlling methods. We
show in Section 5 that some commonly used SNP-set based methods cannot
reach the best detection boundary, and thus are not optimal. In Section 6 we
compare various methods through numerical simulations and the analysis of
a GWAS data of Crohn’s disease. In Section 7 we discuss relevant theoretical
and practical issues. The proofs of the main theoretical results, the funda-
mental lemmas and their proofs, as well as the supplementary figures and
tables, are given in the online supplementary material [Wu et al. (2014)].
2. Genetic model and detection boundary. In this section we character-
ize the detection boundary by introducing a theoretical framework.
We write in model (1)
Xj = (X1j ,X2j , . . . ,Xnj)
′,
so that Xkj is the genotype of the jth SNP for the kth individual, where 1≤
j ≤ L, 1≤ k ≤ n. Let the minor allele Aj of the jth SNP have a minor allele
frequency (MAF) of qj . We assume qj > q > 0, 1≤ j ≤L, for some constant
q. We use the copy number of minor alleles to code the SNP genotype,
which follows a binomial distribution under the Hardy–Weinberg equilibrium
(HWE) [Mendel (1866), Pearson (1904), Yulh (1902)]
Xkj ∼Binomial(2, qj).(2)
In some genetic association studies, the individuals are assumed to be inde-
pendent, that is, Xk1j and Xk2l are independent for any k1 6= k2. However,
the dependency among SNPs, called linkage disequilibrium (LD), is a critical
feature in GWAS data. We characterize the LD structure by the correlation
matrix Σ=ΣL×L among Xk1, . . . ,XkL. For γ > 0 and ∆> 0, let
SL(γ,∆)= {Σ : each row of Σ has no more than
(3)
∆ elements exceeding γ in magnitude}.
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With an appropriately small γ and a moderately large ∆, a matrix Σ in
SL(γ,∆) can be interpreted as sparse, in the sense that each row of Σ has
relatively small coordinates. This setup has been studied in the theoretical
statistics literature [Arias-Castro, Cande`s and Plan (2011)], and is relatively
general and flexible for GWAS because the large correlations are allowed
between SNPs far from each other. In Section 5 we will also consider another
setup for Σ, where the correlation decays polynomially as the SNP distance
increases.
We develop a theoretical framework where we use L as the driving asymp-
totic parameter, and other parameters are tied to L through fixed parame-
ters. In particular, we model the sample size n by
n= nL = L
a for some constant a > 0.(4)
As L grows to ∞, nL grows to ∞ as well. nL can be either larger than or
smaller than L; both cases are common in recent GWAS.
Next, fixing 1/2<α< 1 which we call the rarity parameter, we model the
number of associated SNPs by
K =KL = L
1−α,(5)
so that the fraction of signals tends to 0 as L→∞. In our calibrations,
KL ≪
√
L and the signals are very rare. Seemingly, this is a very subtle
situation. In contrast, the case 0<α< 1/2 is both easier to analyze and less
relevant to the major challenge of the genetic association study, so we omit
the discussion on that. See, for example, Arias-Castro, Cande`s and Plan
(2011), Donoho and Jin (2004).
At the same time, let M∗ ≡ {j1, . . . , jK} be the support of β (or, equiva-
lently, the set of SNPs associated with Y ), and let bj be the sign of βj :
bj = bj(β) = sgn(βj), 1≤ j ≤L,
where sgn(x) = 0,1,−1 if x= 0, x > 0, and x < 0, respectively. From a prac-
tical view, the locations and the directions of the genetic effects are usually
unknown, so we assume the “worst-case” scenario and model bj and M
∗ as
completely random. In other words, for any fixed indices i1 < i2 < · · ·< iK ,
we assume
P (M∗ = (i1, i2, . . . , iK)) =
[(
L
K
)]−1
,(6)
and that given j ∈M∗,
bj =±1 with equal probabilities,(7)
and bj = 0 if j /∈M∗.
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Moreover, let τj be the normalized strength of genetic effect at index j by
τj = |βj |
√
2nqj(1− qj)/σ,(8)
where we note
√
2nqj(1− qj) is approximately equal to the L2-norm of Xj ,
1≤ j ≤ p. Together with the following results, the detection boundary illus-
trates how sample size n, group size L, error deviation σ, genetic effects βj
and MAF qj simultaneously determine the detectability of the genetic sig-
nals through a specific function. For example, for rare variants with reduced
qj , the magnitude of their genetic effects βj need to increase in the same
order of
√
qj(1− qj) to keep the same level of detectability. This result is
valuable for providing a guideline for gene detection in practice.
In the literature [Arias-Castro, Cande`s and Plan (2011), Donoho and Jin
(2004), Ingster (2002)], it is understood that the most delicate case is for all
j ∈M∗,
τj =O(
√
2 log(L)).
In fact, if τj ≫
√
2 log(L) for all j ∈M∗, then the detection problem is easy
and many crude methods can give successful detection. On the other hand,
if τj ≪
√
2 log(L) for all such j, then it is impossible to separate H1 from
H0 and all methods must fail. In light of this, we recalibrate τj through a
so-called strength parameter rj by
τj =
√
2rj log(L),(9)
where rj =O(1) if j ∈M∗ and rj = 0 otherwise. Write r= (r1, r2, . . . , rL)′.
We have the following definition.
Definition. We call (4)–(9) the Asymptotic Rare and Weak model
ARW(a,α,r).
The following notation is frequently used in this paper.
Definition. A test statistic is said to have asymptotically full power if
the sum of its type I and type II error rates converges to 0 for some critical
value. A test statistic is said to be asymptotically powerless if the sum of its
type I and type II error rates converges to 1 for any critical value.
We are now ready to spell out the precise expression of the detection
boundary. The detectability of genetic association between a set of SNPs
and a trait depends on both the proportion of associated SNPs and the
strength of the genetic effects. The sharp detection boundary (i.e., with the
exact constant) relates the rarity and the strength of the genetic effects by
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the curve
r= r∗(α)
in the phase space, where
r∗(α) =
{
α− 1/2, 1/2<α< 3/4,
(1−√1−α)2, 3/4≤ α < 1.(10)
The first main conclusion of this paper is that for any fixed α ∈ (1/2,1), if
rj < r
∗(α) for all j ∈M∗,
then the genetic effects are merely so rare and weak that it is impossible to
separate H1 from H0 asymptotically: all statistical tests are asymptotically
powerless!
Later in Section 3, we show that if there are at least L−α proportion of
genetic effects having rj > r
∗(α), there exist statistical methods, such as the
HC approach to be discussed, that can reliably detect the genetic signal with
asymptotically full power.
To rigorously describe our theoretical results, the technique conditions for
asymptotic analysis are summarized as follows. These assumptions indicate
that the SNP correlation matrix Σ is sparse and guarantee that Σˆ has the
same property as Σ:
(A1) The number of large correlations in each row of Σ is assumed to be
∆=O(Lε) for all ε > 0.
(A2) The correlation γ in (3) and the L–n relative value γ′ =
√
logL
n satisfy
some of the following conditions in different theorems for required
levels of sparsity of Σ:
(A2.1) (γ + γ′)L1−α(logL)4→ 0.
(A2.2) (γ2 + γ′2)L1−α(logL)3→ 0.
(A2.3) (γ + γ′)L1−α→ 0.
(A2.4) γ3 + γ′3 =O(L5α−4+ε) for all ε > 0.
(A2.5) γ + γ′ =O(L−1/2+ε) for all ε > 0.
Theorem 1. Consider the genetic model setup in (1)–(9). Under as-
sumptions (A1) and (A2.1), all tests are asymptotically powerless if rj <
r∗(α), j ∈M∗.
By equations (5) and (8)–(9), for a given proportion of true SNPs L−α,
the detection boundary in (10) implies the boundaries of detectability for
the genetic effects βj , as well as for the genetic heritability of the trait—the
proportion of total trait variation due to genetic variation:
Heritability =
∑L
j=1 β
2
j 2qj(1− qj)∑L
j=1 β
2
j 2qj(1− qj) + σ2
.(11)
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Fig. 1. Left: Detection boundary on the plane of the proportion of associated SNPs and
the genetic effect. Right: Detection boundary on the plane of the proportion of associated
SNPs and the heritability. Solid line: the optimal boundary (reached by HC procedure);
Dashed line: the boundary of the minimal p-value method. Here L = 10,000, n = 1000,
σ = 1 and qj = 0.3 for all j.
For easy visualization of these boundaries, consider a special case where
|βj |= β for j ∈M∗ and qj = 0.3 for all j. The solid lines in Figure 1 illustrate
the detection boundary regarding the genetic effect β (left panel) and the
detection boundary regarding the heritability (right penal) over a range of
the proportion of associated SNPs corresponding to αfrom 0.999 to 0.499.
3. Higher Criticism procedures for gene detection. The Higher Criti-
cism (HC) procedure has been studied for the Gaussian mean model and
regression model with Gaussian design matrix and known error variance
[Arias-Castro, Cande`s and Plan (2011), Donoho and Jin (2004), Hall and
Jin (2010), Ingster, Tsybakov and Verzelen (2010)]. Under the genetic model
setup in (1)–(9), we adopt this procedure for gene detection based on the
marginal associations between the trait and each SNP. We show that the
HC procedure has asymptotically full power upon the rare and weak genetic
effects exceeding the detection boundary.
Let p(1) ≤ · · · ≤ p(L) be the increasingly ordered p-values of L individual
SNPs. The HC test statistic is
HCL = max
1≤j≤L
HCL,j where HCL,j =
√
L
(j/L)− p(j)√
p(j)(1− p(j))
.(12)
In contrast to considering the minimal p-value in a group of SNPs, the HC
considers the maximum of the normalized differences between the empirical
p-values j/L and the observed p-values p(j).
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Denote the survival function of N(0,1) as Φ¯(·). If marginal test statistics
Sj ∼N(0,1), j = 1, . . . ,L, and the p-values are two-tailed, the HC statistic
can be written as [Arias-Castro, Cande`s and Plan (2011), Donoho and Jin
(2004)]
HCL =max
t
HCL(t) where HCL(t) =
|{j : |Sj|> t}| − 2LΦ¯(t)√
2LΦ¯(t)(1− 2Φ¯(t))
.(13)
To study the theoretical properties of the HC procedure, for technical
simplification to obtain the upper bound, we follow Arias-Castro, Cande`s
and Plan (2011) to search for the maximum on a discrete grid and define an
HC∗ procedure with statistic
HC∗L(s) = max{HCL(t) : t ∈ [s,
√
5 logL]∩N}.(14)
In practice, we recommend to still use the straight HC in (12).
To simplify discussion, we first consider the case where σ2 is known. For
the genetic model in (1), let Y¯ = (Y¯ , . . . , Y¯ )′ and X¯j = (X¯j , . . . , X¯j)
′, where
Y¯ = 1n
∑n
k=1Yk and X¯j =
1
n
∑n
k=1Xkj . The test statistic Sj for the associa-
tion between the trait and SNP j is defined as the marginal correlation:
Rσj =
(Xj − X¯j)′Y
σ‖Xj − X¯j‖
,(15)
where ‖x‖ is the L2-norm of a vector x. When SNP j is not associated, we
have Rσj  N(0,1).
Proposition 1 states that the HC∗ procedure reaches the optimal detection
boundary. That is, for some well-controlled type I error rate converging to
0 slowly enough, the statistical power of the HC∗ procedure converges to 1
for detecting the genetic effects that fall above the detection boundary.
Proposition 1. Consider the genetic model setup in (1)–(9). Let the
marginal test statistic Sj in (13) be R
σ
j . Under assumptions (A1), (A2.2)
and (A2.4), HC∗L(
√
2δ logL) with δ =min(1,4r∗(α)) has asymptotically full
power if rj > r
∗(α), j ∈M∗. Furthermore, under assumptions (A1) and
(A2.5), HC∗L(1) has asymptotically full power if rj > r
∗(α), j ∈M∗.
Now we turn to a more realistic case where σ is unknown and cannot
be used in genetic association tests. We propose the following tests that
incorporate σ estimation. Specifically, the marginal association between the
trait and SNP j can be measured by either of the following two test statistics:
Rj =
√
n− 1ρj and Tj =
√
n− 2ρj/
√
1− ρj,(16)
where ρj is the Pearson correlation coefficient between the observed trait
values and the genotypes of the jth SNP. Tj is the standard T -test statistic
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when we regress the trait on the jth SNP. When SNP j is not associated,
both Rj and Tj  N(0,1). Note that Rj and Tj are asymptotically equiv-
alent because ρj → 0 under the ASW(a,α,r) model for both the null and
the alternative hypotheses. The numerical results in Section 6 also show
that their performances are very similar in simulations and real GWAS data
analysis.
When σ is unknown, we need a slightly stronger condition than that in
Proposition 1 to guarantee the proper behavior of the σ estimation. The
following theorem shows that the HC∗ procedure based on Rj still reaches
the detection boundary.
Theorem 2. Consider the genetic model setup in (1)–(9). Let the mar-
ginal test statistic Sj in (13) be Rj . Under assumptions (A1), (A2.3) and
(A2.4), HC∗L(
√
2δ logL) with δ =min(1,4r∗(α)) has asymptotically full power
if rj > r
∗(α), j ∈M∗. Furthermore, under assumptions (A1) and (A2.5),
HC∗L(1) has asymptotically full power if rj > r
∗(α), j ∈M∗.
Figure 1 illustrates that the detection boundary for the HC∗ procedure is
the same as the optimal detection boundary.
4. Connections to FDR-controlling methods. Tukey’s Higher Criticism
(HC) is closely related to methods of controlling the False Discovery Rate
(FDR) [e.g., Benjamini and Hochberg (1995), Efron et al. (2001)], but is also
different in important ways. While there is a long line of works on FDR con-
trolling methods, for reasons of space, we focus our discussion on Benjamini
and Hochberg’s FDR-controlling method (BH), proposed in Benjamini and
Hochberg (1995). The connection and difference between HC and BH can
be briefly summarized as follows:
• Both BH and HC are p-value driven methods, the use of which needs only
the p-values associated with all SNPs.
• BH focuses on the regime where the signals are rare but relatively strong,
and the goal is signal identification.
• HC focuses on the regime where the signals are so rare and weak that
signal identification is frequently impossible, but valid signal detection or
screening is still possible and could be substantially helpful.
Let p(1) ≤ p(2) ≤ · · · ≤ p(L) be the sorted p-values associated with L SNPs.
The formulas of HC and BH are intimately connected. In detail, fix the
FDR-control parameter α ∈ (0,1) (say, α= 5%). The goal of BH is usually
to control the expected fraction of false discovered SNPs out of all discovered
SNPs (i.e., the FDR) so that it does not exceed α. The procedure selects
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the SNPs whose p-values are among the kFDRα -smallest as discoveries, where
kFDRα is the largest integer k such that
Qk ≤ α where Qk =
p(k)
k/L
.
When min1≤k≤L{Qk}> α, BH reports an empty set of discoveries. Qk is a
quantity that has been extensively studied in empirical processes. See, for
example, Wellner (1978).
Following the same argument on page 975 of Donoho and Jin (2004), it can
be shown that for any testing critical value
√
2q log(L) with any 0< q < 1,
the ratio between the expected number of recoveries under the alternative
[with signal slightly above the detection boundary in (10)] and the expected
number of recoveries under the null is about 1. So the problem of BH for the
rare and weak signal (which may be interesting targets in GWAS) is that
min
1≤k≤L
{Qk} ≈ 1.(17)
As a result, for any α that is bounded away from 1 (say, α≤ 90%), the BH
method reports an empty set of discoveries. The BH method could produce
a nonempty set of discoveries if we let α get even closer to 1, but the FDR
is so high that the set of discoveries is no longer informative for signal
identification.
We will never know what was in Tukey’s mind when he proposed the
Higher Criticism in 1976 [Tukey (1976)], but there is an interesting con-
nection between HC and BH (which was proposed about 20 years later) as
follows. Suppose we apply Qk to the HC statistic in (12). Heuristically, if
k≪ L and (17) holds,
HCL,k ≈
√
k(1−Qk).
As before, think of the signal detection problem as testing a null hypothesis
H0 versus an alternative hypothesis H
(L)
1 . In the null case where all p-values
are i.i.d. from U(0,1) and so that data contains no signal at all, then HCL,k ≈
N(0,1) for all k, and HCL,k are uniformly bounded from above by a relatively
small number, say, 3. In the alternative case where the p-values come from
rare and weak signals, even when Qk ≈ 1 for all k, it is still possible that for
some k,
HCL,k ≈
√
k(1−Qk)≫ 1.
This fact says that even when signals are so rare and weak that signal
identification (say, by BH) is impossible, there could still be ample space
for valid inference (e.g., screening or signal detection), and HC is such a
tool. Partially, we guess, this is the reason why Tukey interprets HC as the
second-level significance testing.
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Denote the maximizing index k for HCL,k by
kHC = argmax
1≤k≤L
{HCL,k}.
Such an index is very different from kFDRα . The index suggests a very in-
teresting phenomenon that is frequently found for rare and weak signals
(however, the phenomenon is not that frequently found when signals are
rare and strong). Specifically, it is not always the case that kHC = 1; it
could happen that the index is larger than 1, say, kHC = 50. When this phe-
nomenon happens, the interpretation is that the strongest evidence against
the null is not necessarily the smallest p-value, but is the collection of mod-
erately smallest p-values; see Donoho and Jin (2004) for discussion on mod-
erate significances. When moderate significances contain more information
for inference than does the smallest p-value, the HC type methodology is
frequently more appropriate than BH, where the goal is shifted from signal
identification to detection, to accommodate the presence of weak signals.
5. Some other gene detection procedures. With the genetic detection
boundary we can show that many well-known SNP-set methods are not
optimal for the rare and weak genetic effects. First, we consider the min-
imal p-value method that treats the smallest p-value in a SNP-set as the
measurement for the association between the trait and the SNPs in the set.
The following proposition considers the minimal p-value method under cases
where σ is either known or unknown.
Proposition 2. Consider the genetic model setup in (1)–(9). Under the
assumptions (A1) and (A2.2), the minimal p-value procedure based on Rσj
has asymptotically full power if rj > r
MP(α), j ∈M∗, and is asymptotically
powerless if rj < r
MP(α), j ∈M∗, where
rMP(α)≡ (1−√1−α)2, α ∈ (1/2,1).
Furthermore, under assumptions (A1) and (A2.3), the minimal p-value pro-
cedure based on Rj has asymptotically full power if rj > r
MP(α), j ∈M∗,
and is asymptotically powerless if rj < r
MP(α), j ∈M∗.
Proposition 2 shows that the minimal p-value method is not optimal be-
cause rMP(α) > r∗(α) for α ∈ (1/2,3/4). Figure 1 illustrates the comparison
between the minimal p-value method (dashed curve) and the HC procedure
(solid curve) regarding the genetic effect (βj = β for all j ∈M∗) and the her-
itability. When the associated SNPs are extremely rare with α ∈ (3/4,1), the
two methods have the same detection boundary. However, in a wide range
of the proportion of associated SNPs corresponding to α ∈ (1/2,3/4), the
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HC procedure can detect significantly weaker genetic effects and heritabil-
ity than the minimal p-value method does. This regime is more important
in combating the detection of the undiscovered common and rare genetic
variants that could number in the hundreds [Goldstein (2009), Hall, Jin and
Miller (2009), Kraft and Hunter (2009), Wade (2009)].
We further consider three commonly used SNP-set methods in the GWAS
literature [Luo et al. (2010)] and show that they are not as good as the
minimal p-value method under our model setup. Let S= (S1, . . . , SL)
′ be a
vector of marginal test statistics and Σˆ be the Pearson correlation coeffi-
cients among the SNP genotypes, that is, Σˆ(i, j) =
(Xi−X¯i)
′(Xj−X¯j)
‖Xi−X¯i‖‖Xj−X¯j‖
. First,
the linear combination test (LCT) statistic is defined as
TL = e′S/
√
e′Σˆe,(18)
where e is the vector of 1s. Second, when Σˆ
−1
exists, the quadratic test
(QT) statistic is defined as
TQ = S′Σˆ
−1
S.(19)
Third, the decorrelation test (DT) statistic is the Fisher’s combination test
after the decorrelation generating independent p-values:
TD =−2
L∑
j=1
log pj,(20)
where the p-values pj = 2Φ¯(|Wj |) and Wj is the jth element of W=D−1S,
where D is a triangular matrix of Cholesky decomposition such that Σˆ =
DD
′. The following theorem says that LCT, QT and DT are not optimal for
rare and weak effects when SNPs are independent or have a polynomially
decaying correlation along the distance between the SNPs. Specifically, for
the true correlation matrix among the SNPs Σ, we denote the operation
norm as ‖Σ‖= sup{a : ‖a‖2=1} ‖Σa‖2. Σ has a polynomial off-diagnal decay
if for positive constants M , λ and C, the magnitude of the (j, k)th element
is upper bounded by a polynomial function
|Σ(j, k)| ≤M(1 + |j − k|)−λ and ‖Σ‖ ≥C > 0.(21)
Theorem 3. Consider the genetic model setup in (1)–(2), (4)–(9) and
(21). The three tests in (18)–(20) correspond to S= (R1, . . . ,RL)
′, where Rj
is defined in (16). Let γ′ =
√
logL
n . For any λ ≥ 3, M ≥ 1 and γ′L= o(1),
LCT does not have asymptotically full power when rj < 1, j ∈M∗. For
any λ > 1 and γ′Ld = o(1) for some d > 1, both QT and DT do not have
asymptotically full power when rj < 1, j ∈M∗.
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Because the detection boundary rMP(α) of the minimal p-value method
is always less than 1 for each α ∈ (1/2,1), the SNP-set methods LCT, QT
and DT have poorer performance than the minimal p-value method. In par-
ticular, this theorem indicates that Fisher’s combination test (such as DT)
is not a good choice for the rare and weak genetic effects considered here.
6. Simulations and Crohn’s disease study. Simulations and real GWAS
analysis are conducted to evaluate the performance of HC-type methods and
other traditional and newly proposed gene-based SNP-set methods, in which
SNP genotypes in genes form sets of covariates. Instead of finding individual
causative SNPs, the goal of signal detection here is to test which genes
may contain these causative SNPs. Although the above theoretical results
focus on model (1), in order to guide practical applications, we study both
quantitative and binary traits in the following analysis of three types of data
sets (Table 1): both simulated genotypes and phenotypes, real genotypes and
simulated phenotypes, and both real genotypes and phenotypes for Crohn’s
disease study. The following summarizes the implementation of the methods
to be compared:
1. Higher Criticism method. The test statistic is given in (12) for each
gene. For quantitative traits, the p-values are calculated based on either Tj
(method denoted HC) or Rj (denoted HCm) in (16). For binary traits, we
adopt a Z-statistic by Zuo, Zou and Zhao (2006) (denoted HC):
Dj =
√
n
pˆcase − pˆcontrol√
2pˆall(1− pˆall)
,(22)
where pˆcase, pˆcontrol and pˆall are the estimated MAF in cases, controls and the
combined group, respectively. When the jth SNP is not associated, Dj  
N(0,1), the two-tailed p-values pj = 2Φ¯(|Dj |) are applied to (12) to get the
HC statistic.
2. Minimal p-value method (denoted MinP). The association of a SNP
set in a gene is determined by the smallest p-value p(1). This is the most
commonly used method in GWAS practice. The p-values are obtained either
based on Tj in (16) for quantitative traits or Dj in (22) for binary traits.
3. Principal Component Analysis (PCA) [Ballard, Cho and Zhao (2010),
Wang and Abbott (2008)]. To measure the significance of a gene, a p-value is
obtained by fitting a multiple regression for quantitative traits (or a logistic
regression for binary traits) by using the least principal components that
count over 85% variation.
4. Ridge regression (denoted Ridge) [He and Wu (2011)]. SNP covariates
in a gene are fitted with traits by ridge regression at the tuning parameter
that minimizes the prediction error based on cross-validation (R function
lm.ridge). The residual sum of squares describes the goodness of fit of the
model, and thus is treated as the score for the SNP set. The same procedure
is applied to both quantitative and binary traits for simplicity.
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5. Linear combination test (LCT), quadratic test (QT) and decorrela-
tion test (DT) [Luo et al. (2010)]. To calculate the statistics in (18)–(20),
we apply S = (T1, . . . , TL)
′ with Tj in (16) for quantitative traits and S =
(D1, . . . ,DL)
′ with Dj in (22) for binary traits.
6. Kernel-machine test [Wu et al. (2010)]. This is a SNP-set method that
applies the generalized semiparametric models [Liu, Lin and Ghosh (2007),
Wu et al. (2010)] to detect the association of genes. For the additive genetic
model defined in (1), the linear kernel function is recommended by the au-
thors [Wu et al. (2010)]. So the semiparametric model is simplified to either
a multiple regression model for quantitative traits (denoted KMT) or logis-
tic regression for binary traits (denoted LKMT). The genetic association is
measured by a variance-component score statistic [Zhang and Lin (2003)].
We apply the R functions implemented by the authors of this method.
6.1. Simulated genotypes and phenotypes. We simulated both genotype
and phenotype data to fully control the data structure and genetic effect
pattern. Data sets 1 and 2 in Table 1 were obtained in the following. First,
to simulate the genotype data, it was assumed that one gene unit contains
Table 1
List of the data used for analysis. Genotypes are either simulated based on six Toeplitz
correlation matrices (TCM) or from the true GWAS data of NIDDK–IBDGC. The
number of SNPs per gene is either 100 or according to the true data. Phenotypes are
either simulated based on the additive model (σ2 = 1) or logistic regression model
(β0 =−2) or the true Crohn’s disease status. The locations of nonzero coefficients are
always random and the values are either fixed or random, where b1 ranges from 0.088 to
0.131 and b2 ranges from 0.1 to 0.24
Data Genotype Sample SNPs/gene LD MAFPhenotype Nonzero coefficients
1 Simulation 1000 100 6 TCM 0.4 Additive 3, b1
2 Simulation 2000 100 6 TCM 0.4 Logit 3, b2
3 Simulation 1000 100 6 TCM 0.4 Additive 3, +/−b1 equal chance
4 Simulation 1000 100 6 TCM 0.4 Additive 3, Unif[b1,1.2b1]
5 Simulation 1000 100 6 TCM 0.4 Additive 3, Unif[0.9b1,1.1b1]
6 BCHE 851 Jew 100 real real Additive 3, b1
7 BCHE 851 Jew 100 real real Logit 3, b2
8 EXT1 851 Jew 106 real real Additive 3, b1
9 EXT1 851 Jew 106 real real Logit 3, b2
10 FSHR 851 Jew 117 real real Additive 3, b1
11 FSHR 851 Jew 117 real real Logit 3, b2
12 15,860 genes 851 Jew vary real real Additive α= 0.8, r = 0.9
13 15,860 genes1145 non-Jewish vary real real Additive α= 0.8, r = 0.9
14 15,860 genes 851 Jew vary real real CD status –
15 15,860 genes1145 non-Jewish vary real real CD status –
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L = 100 SNPs, whose genotypes follow HWE in (2) with MAF q = 0.4.
To demonstrate how typical LD structures may affect these methods, six
Toeplitz correlation matrices (TCM) were studied: (I) Independent SNPs,
that is, the correlation matrix Σ is the identity matrix. (II) SNPs in the first
order neighborhoods are correlated, that is, Σ has 1 in the main diagonal,
0.3 (or 0.25, or 0.2) in the first off-diagonals and 0 elsewhere. (III) SNPs are
correlated with the nearest two neighbors, that is, Σ has 1 in the main diag-
onal, 0.25 in the first off-diagonal, 0.3 (or 0.2) in the second off-diagonal and
0 elsewhere. The R package mvtBinaryEP [By and Qaqish (2011), Emrich
and Piedmonte (1991)] was used to generate the correlated genotype data.
Second, to simulate the phenotype data, we considered the cases of rare
and weak genetic effects based on the above theoretical results. Specifically,
the rarity parameter was assumed α = 0.76, so K = L1−α ≈ 3 randomly
picked SNPs were made causative. Quantitative traits were generated by
model (1) with error variance σ2 = 1. The sample size was n = 1000. We
examined a series of strength parameters rj = r in (9) from 0.4 to 0.9, which
correspond to the genetic effects βj in (8) equals b1 ranging from 0.088 to
0.131, and the heritability of trait ranging in (11) from 0.011 to 0.024. On
the other hand, binary traits were generated by a logistic model
logit
(
P (Y = 1|X)
P (Y = 0|X)
)
= β0 + β1X1 + β2X2 + · · ·+ βLXL.(23)
Conditional on the genotype data, many diseased (Y = 1) and nondiseased
outcomes (Y = 0) were generated according to the genetic risk. Then the ret-
rospective case–control data were collected by randomly sampling 1000 cases
and 1000 controls. We considered the coefficient β0 =−2 and a sequence of
nonzero coefficients βj = b2 ranging from 0.10 to 0.24, which correspond to
the disease allele odds ratio ranging from 1.11 to 1.27.
The empirical power was compared based on a well-controlled empirical
type I error rate. Specifically, we ran 1000 simulations, each with newly
generated genotypes, and then the phenotypes according to a specific genetic
model with random locations of causative SNPs. For each simulation, we also
permuted the phenotype responses and calculated the test statistics for the
null hypothesis of no association. Over all simulations, the 95th percentile
of the null statistics was used as the cutoffs to control the type I error
rate at a level 0.05. The empirical power, that is, the true positive rate of
tests, is the proportion of simulations where the test statistics exceeded the
corresponding cutoff. Figures 2 and 3 show the comparisons of empirical
power for data sets 1 and 2, respectively. In all the setups, the HC-type
methods had the highest power. The comparisons were not significantly
affected by these LD structures.
In reality, causative SNPs may not have homogenous contribution to the
traits. We simulated data sets 3–5 described in Table 1 for three scenar-
ios of random genetic effects. First, the nonzero coefficients have the same
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Fig. 2. For quantitative traits under the fixed value of nonzero coefficients, HC and
HCm have the highest power. X-axis: the strength parameter r in equation (9), which
corresponds to the nonzero coefficients βj = b1 in (8). The six panels correspond to six
correlation matrices of SNPs: (1) identity matrix, (2) the 1st off-diagonals equal 0.3, (3)
the 1st off-diagonals equal 0.25, (4) the 1st off-diagonals equal 0.2, (5) the 1st off-diagonals
equal 0.25 and the 2nd off-diagonals equal 0.3, (6) the 1st off-diagonals equal 0.25 and the
2nd off-diagonals equal 0.2.
Fig. 3. For binary traits from the fixed value of nonzero coefficients, HC has the highest
power. X-axis: the nonzero coefficients βj = b2 in equation (23). The six panels correspond
to the same six correlation matrices of SNPs as those in Figure 2.
HIGHER CRITICISM FOR RARE AND WEAK GENETIC EFFECTS 19
Fig. 4. For quantitative traits from random nonzero coefficients ±b1 with equal probabil-
ities, HC and HCm have the highest power. X-axis: the strength parameter r in equation
(9), which corresponds to the nonzero coefficients βj = b1 in (8). The six panels correspond
to the same six correlation matrices of SNPs as those in Figure 2.
magnitude b1, but with random +/− signs of equal probabilities. Second,
the nonzero coefficients are uniformly distributed in [b1,1.2b1]. Third, the
nonzero coefficients are uniformly distributed in [0.9b1,1.1b1]. Figure 4 shows
the comparisons of the methods under random nonzero coefficients ±b1 with
equal probabilities. HC methods were still the best among these methods
assessed. Since the genetic effects have two directions, the linear combina-
tion test (LCT) causes the signals to cancel out and has low power. The
results for the other two scenarios of random genetic effects (data sets 4–5
in Table 1) are given in supplementary Figures 1 and 2 [Wu et al. (2014)].
Our theoretical results in Sections 3–5 are about reliable detection, that
is, to get asymptotically full power of detecting true genes containing a
small number of weak causative SNPs. In reality, the sample size may not
be large enough to allow the power approaching to 1, and there is a chance of
obtaining false discoveries. Here we assessed the False Discovery Rate (FDR)
of these methods over a variety of type I error rate cutoffs. Figure 5 illustrates
the FDR of HC methods for quantitative traits (Data 1 in Table 1), with
the strength parameter r = 0.4–0.9. It can be seen that the FDR is well
controlled, with an expected decreasing trend for increasing signal strength
r. The HC method was also compared with other methods in terms of the
FDR in supplementary Figures 3–8 [Wu et al. (2014)]. The FDR of the HC
method is similar to or lower than those of the other methods.
6.2. Real genotypes and simulated phenotypes. By using real genotype
data, we studied how the real allelic distributions and LD structures, which
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Fig. 5. False Discovery Rates of the HC method for quantitative traits. X-axis: the empir-
ical type I error rate cutoff. The six panels correspond to the same six correlation matrices
of SNPs as those in Figure 2.
are more complicated than the above simulations, may influence the re-
sults. For this purpose, we used the observed SNP genotypes from the data
of NIDDK–IBDGC (National Institute of Diabetes, Digestive and Kidney
Diseases–Inflammatory Bowel Disease Genetics Consortium) [Duerr et al.
(2006)]. The data contain 851 independent subjects from the Jewish pop-
ulation (417 cases and 434 controls) and 1145 independent subjects from
the non-Jewish population (572 cases and 573 controls). SNPs were grouped
into 15,860 genes on chromosomes 1–22 according to physical locations of
genes and SNPs (NCBI Human Genome Build 35). For data quality control,
SNPs were excluded if they have HWE p-values less than 0.01 or MAF less
than 0.01. SNPs were also removed if their genotypes are redundant or have
a missing rate over 10%. The final data set contains 307,964 SNPs. The gene
length (number of SNPs) ranges from 1 to 844 and is highly skewed to the
right: the lower, median and upper quartiles are 3, 7 and 19, respectively.
The missing genotypes were imputed as the average over subjects.
Quantitative and binary traits were simulated under similar setups of
rare and weak genetic effects as those in Section 6.1. Data sets 6–11 in
Table 1 list the parameters and setups based on three genes: BCHE (bu-
tyrylcholinesterase) is a gene with 100 SNPs located at 3q26.1-q26.2; EXT1
(exostosin 1) is a gene with 106 SNPs located at 8q24.11; FSHR (follicle
stimulating hormone receptor) is a gene with 117 SNPs located at 2p21-p16.
At the empirical type I error rate 0.05 from 1000 simulations, Figure 6 shows
the empirical power of testing these genes through quantitative (row 1) and
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Fig. 6. Power comparison based on genotype data of genes BCHE (left), EXT1 (middle)
and FSHR (right), respectively. Row 1 X-axis: the strength parameter r for the genetic
effect in equation (9) for the quantitative trait model; row 2 X-axis: the genetic effect β in
equation (23) for the binary trait model.
binary traits (row 2). It is clear that HC procedures performed similarly to
or better than the other SNP-set methods.
We further studied the performance of these gene-detection methods when
causative SNPs are simultaneously located within multiple risk genes. Specif-
ically, we took 10 genes found to be associated with Crohn’s disease (CD)
in the literature [Franke et al. (2010)] and made each of these contain L1−αg
causative SNPs (rounded to integer), where Lg is the number of SNPs in
the gth risk gene. The locations of these associated SNPs in each risk gene
were randomly chosen. The quantitative traits were then generated by an
additive model (1) that contains all the causative SNPs from the 10 risk
genes, where each causative SNP has a genetic effect βj defined in (8)–(9)
with the rarity parameter α= 0.8 and the strength parameter rj = 0.9. After
generating the quantitative trait, we carried out the GWA study by using
the whole genotypes data of all 15,860 genes. Data sets 12 and 13 in Table 1
summarize the information on the parameters and setups.
To accommodate the fact that genes have distinct numbers of SNPs and
LD structures, we again adapted the permutation test by randomly shuffling
the response traits for obtaining the gene-by-gene empirical p-values. For
the 10 risk genes, Tables 2 and 3 show their empirical p-values from 10,000
permutations as well as the corresponding ranks (ties are averaged) among
all 15,860 genes based on Jewish and non-Jewish data, respectively. Only
HC methods reliably had the smallest average p-values and ranks for both
data sets.
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Table 2
Based on the NIDDK–IBDGC Jewish genotype data and the additive genetic model that contains 10 risk genes for Crohn’s disease, all
15,860 genes were tested by gene-based SNP-set method, and were ranked based on their empirical p-values. The ranks and p-values of
the 10 risk genes for each method are listed, and their averages are shown in the last row
MinP LCT QT KMT HC HCm
Genes SNPs/gene Rank p-value Rank p-value Rank p-value Rank p-value Rank p-value Rank p-value
IL23R 23 490 0.0314 1772 0.1138 2337.5 0.1577 23 0.0007 109.5 0.0071 104.5 0.0069
PTGER4 72 3984.5 0.2496 14,246 0.901 2885 0.1931 490 0.0309 470.5 0.0313 455 0.0298
IL12B 41 2.5 0 15,574.5 0.9831 11.5 0.0006 3 0 2.5 0 2.5 0
CDKAL1 160 2245.5 0.1423 4481 0.2859 6418.5 0.4155 150 0.0084 534.5 0.0352 506.5 0.0335
PRDM1 71 4801.5 0.3029 2908 0.1858 5735.5 0.3733 8203 0.5243 8290 0.5243 8327 0.5275
ZNF365 54 2.5 0 1809.5 0.1159 22 0.0013 8 0.0002 2.5 0 2.5 0
PLCL1 64 1708.5 0.1092 8957 0.564 7353.5 0.4751 338 0.0194 807.5 0.0505 768.5 0.049
BACH2 83 2.5 0 9747.5 0.6118 384 0.0274 3 0 2.5 0 2.5 0
GALC 120 919 0.0578 15,391 0.972 7146.5 0.4612 1392 0.0948 936 0.0589 924.5 0.0581
SMAD3 52 5806.5 0.3642 4193 0.268 3079 0.2041 5456 0.359 4985.5 0.3135 5024 0.316
Average 74 1996.3 0.1257 7907.95 0.5001 3537.3 0.2309 1606.6 0.1038 1614.1 0.1021 1611.9 0.1021
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Table 3
Same analysis as that for Table 2, except by using the NIDDK–IBDGC non-Jewish genotype data
MinP LCT QT KMT HC HCm
Genes SNPs/gene Rank p-value Rank p-value Rank p-value Rank p-value Rank p-value Rank p-value
IL23R 23 7184 0.4638 13,952.5 0.8833 3800.5 0.2603 4979 0.3379 5626 0.3584 5635 0.3587
PTGER4 72 4627.5 0.2965 3859 0.2509 2983 0.2048 2080 0.1396 2327.5 0.1449 2318.5 0.1446
IL12B 41 35 0.0016 48 0.0026 2552.5 0.1751 167 0.0075 29 0.0014 29.5 0.0013
CDKAL1 160 3 0.0001 393 0.0246 3.5 0.0001 38 0.0011 4.5 0.0002 5.5 0.0002
PRDM1 71 878 0.0529 9258.5 0.5888 8300.5 0.5427 41 0.0012 543 0.0322 517.5 0.0304
ZNF365 54 6080.5 0.3912 4873 0.313 4021 0.2741 7593 0.4941 6857 0.4398 6837 0.4379
PLCL1 64 1071 0.0656 404.5 0.0253 9475 0.6181 1048 0.0665 768 0.0479 777 0.048
BACH2 83 2357.5 0.1469 11,721.5 0.7461 1055.5 0.069 2382 0.1591 1711 0.1065 1648.5 0.1032
GALC 120 379.5 0.0232 14,902 0.9419 299.5 0.0209 45 0.0014 57.5 0.0033 58.5 0.0033
SMAD3 52 119 0.0069 13,274.5 0.8428 952 0.0632 2378 0.1588 98 0.0052 96 0.0051
Average 74 2273.5 0.1449 7268.7 0.4619 3344.3 0.2228 2075.1 0.1367 1802.2 0.1140 1792.3 0.1133
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6.3. Real GWAS of Crohn’s disease. Crohn’s disease primarily causes ul-
cerations of the small and large intestines, which affects between 400,000 and
600,000 people in North America alone [Baumgart and Sandborn (2007),
Loftus, Schoenfeld and Sandborn (2002)]. To detect novel risk genes of
Crohn’s disease, we applied the above gene-based SNP-set methods to the
NIDDK–IBDGC data that contain both real genotypes and Crohn’s disease
status as the phenotype (see data sets 14 and 15 in Table 1).
The genetic architecture of Crohn’s disease remains unclear. One way to
partially compare the above methods for detecting remaining risk genes is to
base on risk genes that have similar properties as those undiscovered ones. In
particular, we studied a set of 41 recently reported putative genes that likely
contain such SNPs with rare and weak genetic effects to the susceptibility of
Crohn’s disease [Table 2 of Franke et al. (2010)]. The empirical p-values and
the corresponding ranks for these 41 genes are summarized in supplementary
Tables 1 and 2 in the supplementary materials [Wu et al. (2014)] for the
Jewish data and the non-Jewish data, respectively. For both data sets the
HC method provided higher average ranks for the 41 risk genes than the
other methods.
For the top 96 ranked genes by HC and those by MinP methods, 87 of
them are common. Nine genes were included in the top 96 genes by HC,
but not by MinP: PFAAP5, AGTR1, CDA08, NXPH1, LCN10, OR51G1,
FDXR, KIAA1904, and EDG1. Interestingly, by the Catalogue of Somatic
Mutations in Cancer (COSMIC), all nine genes contain one or more ge-
netic variations associated to the tumor site on the large intestine. Some of
these genes are likely to be relevant according to their functions. For exam-
ple, PFAAP5 (human phosphonoformate immuno-associated protein 5) on
chr13 is likely related to Crohn’s disease, a disease of the immune system.
AGTR1 (Angiotensin II receptor type 1) on chr3 involves positive regu-
lation of inflammatory response [The UniProt Consortium (2012)] and is
associated with the increase of immunoglobulin [Wallukat et al. (1999)]. As
a critical antibody in mucosal immunity, 3–5 grams of immunoglobulin is
secreted daily into the intestinal lumen [Brandtzaeg and Pabst (2004)]. For
NXPH1 (neurexophilin 1) on chr7, neurexophilins are signaling molecules
that resemble neuropeptides by binding to alpha-neurexins and possibly
other receptors. This gene may be relevant because Crohn’s disease can also
present with neurological complications. Gene LCN10 is potentially relevant
because biopsies of the affected colon of Crohn’s patients may show mucosal
inflammation, characterized by focal infiltration of neutrophils, a type of
inflammatory cell, into the epithelium [Baumgart and Sandborn (2012)].
Gene EDG1 (endothelial differentiation gene 1) has regulatory functions in
normal physiology and disease processes, particularly involving the immune,
and influences the delivery of systemic antigens [Arnon et al. (2011)]. Fur-
thermore, genes AGTR1, CDA08, OR51G1 and EDG1 correspond to the
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components integral to membranes [Binns et al. (2009)], thus are also linked
to Crohn’s disease, which is categorized as a membrane transport protein
disorder. Certainly, further biological validations are needed to confirm how
these genes are related to Crohn’s disease.
7. Discussion. This paper makes several contributions to the literature.
First, it considers the detection boundary for rare and weak genetic effects
in the GWAS setting. Second, our approach allows for marker dependencies
(LD) and unknown error variance, which are lacking in theoretical consider-
ation in the literature and are better aligned with practical GWAS settings.
Third, it shows that some of the commonly used SNP-set methods are sub-
optimal. Fourth, it proposes a HC-based method to evaluate the statistical
evidence of association between a set of SNPs and a complex trait. We show
that this method achieves the most power for the specified rare and weak ge-
netic effect setting. Application of this method to the second wave of GWAS
will likely help researchers identify more trait-associated genes.
Because the values of R- or T -test statistics in (16) depend on the correla-
tions among the genotypic covariates, the HC procedure for optimal gene de-
tection implicitly incorporates the LD information into the hypotheses test-
ing. For example, those SNPs correlated with an associated SNP likely have
larger magnitude of their R- or T -test statistics and thus smaller marginal
p-values. So the maximization procedure in (12) can capture this informa-
tion to strengthen the genetic signal. At least in the polynomially decaying
correlations defined in (21), this implicit LD-incorporation is asymptotically
more powerful than some commonly applied procedures that explicitly cal-
culate and incorporate the correlation matrix into constructing test statistics
[Luo et al. (2010)], as is illustrated by Theorem 3.
This paper sheds some light on the power of genetic association studies
based on marginal association tests versus joint association tests [Genovese,
Jin and Wasserman (2009)]. One interesting discovery of this paper is that
the HC procedure based on marginal association tests has actually reached
the optimal detection boundary for the additive genetic model in (1). That
is, the merit of joint association analysis is probably not for the additively
joint genetic effects, but rather for gene–gene interactions [Wu and Zhao
(2009, 2012)].
Although we have derived some theoretical results in this paper, and the
general setup may be a reasonable abstraction of the real model, the as-
sumptions considered are still relatively simple and may not capture the
complexity of the real genetic architecture. For example, we did not con-
sider potential gene–gene interactions that are believed to play an important
role in biological systems. However, our work does represent advances over
the simpler setup in the literature [Arias-Castro, Cande`s and Plan (2011),
Donoho and Jin (2004)], with the allowance of genotype covariates and un-
26 Z. WU ET AL.
known environmental variance. Our theoretical results offer insights on the
relative performance of different methods, which were supported by results
from simulation and practical GWAS.
Our current work can lead to several future research topics in statistical
genetics. The empirical null distribution may depart from N(0,1) in large
scale data due to unobserved covariates and/or correlations [Efron (2004,
2007a, 2007b)]. It is important to address how likely this problem could
arise in gene-based detection in GWAS, and how to theoretically and prac-
tically address the issue in detecting sparse heterogeneous mixtures. From
a genetics perspective, first, it would be interesting to study more complex
genetic models, such as those measuring gene–gene interactions. Second, the
proposed HC procedure can be extended to broader applications in genetic
studies. We have illustrated the methods for gene detection based on SNP-
sets grouped within genes. Depending on the scientific interests, SNPs can
also be grouped based on other genomic segments or based on pathways
containing sets of relevant genes [Luo et al. (2010), Yu et al. (2009)]. For
example, in a pathway analysis, we can directly calculate the HC statistics
using all individual SNPs within the pathway. We can also construct a two-
level study, in which we calculate p-values for genes, for example, by the
goodness-of-fit test [Donoho and Jin (2004), Section 1.6] for all SNPs within
those genes, then use p-values of genes to calculate an HC type statistic for
each pathway. These strategies will be investigated in further research.
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SUPPLEMENTARY MATERIAL
Supplement to “Detection boundary and Higher Criticism approach for
rare and weak genetic effect” (DOI: 10.1214/14-AOAS724SUPP; .pdf). We
provide the proofs for main theoretical results, the fundamental lemmas and
their proofs, as well as additional figures and tables that show performance
of Higher Criticism in comparing with other methods under a variety of
setups.
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